Studying therapeutic effects of Methylprednisolone Acetate and Lidocaine injection in patients with Fibromyalgia

Phase 3

Recruiting

• Conditions: Fibromyalgia.; Fibromyalgia; M79.7

• Registration Number: IRCT20210308050630N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

patient diagnosed with fibromyalgia base on American College of Rheumatology guideline.
Completing and signing the conscious consent form
Abdominal pain, depression and headache for the last 6 mounths.
pain in dfferent parts of body like Neck-Jaw-Shoulder-upper Arm-lower Arm-Chest-Abdomen-Back-upper Thigh at both sides of the body for the last week
problems like weakness ,after sleep fatigue, impaired thought and memory for the last week

Exclusion Criteria

Patients with Diabetes mellitus-Thyroid disease-Neuropathy-Lyme disease-Hepatitis
patients who use medications like ASA-Metoclopramide-Tamoxiphen-TCA-alfa agonists-Beta cyprotrone
uncontroled mental illness

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body pain. Timepoint: Before treatment-2-4-8 weeks later. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Functional status. Timepoint: Before treatment -2-4-8 weeks after treatment. Method of measurement: FIBROMYALGIA IMPACT QUESTIONNAIRE (FIQ ).